drugset / Trial / NCT01992211

Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin

NCT01992211 ↗

Phase 1 Completed 35 enrolled BC World Pharm Co. Ltd.
RandomizedCrossoverOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the pharmacokinetic Profile and Safety/Tolerability of BCWP\_C003 compared to Co-Administration of Crestor 10mg and Glucophage XR 1000mg, and to evaluate the food effect of Pharmacokinetic profile of BCWP\_C003 after administration.

Timeline

Start
2016-12-15
Primary completion
2017-04-28
Completion
2017-07-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BCWP_C003 Unknown — Oral
Subject Metformin Small molecule 1000 mg Oral
Subject Rosuvastatin Small molecule 10 mg Oral

Indications

No indication recorded.